Search

everythinglearnresearchcommunity

for

Search:↓

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Deep Plane Fixation in scalp surgeries allows for more tissue removal with less tension and minimal scarring.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride effectively treats male hair loss, increasing length and thickness.

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

Cyclosporin doesn't stop hair loss.

Niosomes improve minoxidil skin delivery for hair loss treatment.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Improved hair loss treatment using special particles and surfactants.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

PRP therapy safely improves hair growth in people with hair loss.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

PRP and cell therapies may help with hair loss, but more research is needed.

LLLT is a safe, promising hair loss treatment, but more research needed.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Artificial dermal template treatment can stimulate complete skin and hair follicle regrowth.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Certain cultural hair practices might cause baldness by affecting natural hair oils and stem cell delivery to hair follicles.